cjc-1295 ipamorelin igf-1 increase clinical trials KLOW KLOW - Dr Explains The

Take the dosage as prescribed by a doctor

Research context and laboratory endpoints 1

Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing

But none of us should settle for inadequate rest, because our health takes a hit: Poor sleep is associated with increased risk of coronary heart disease, osteoporosis, and decreased cognitive function, as well as overall mortality

But supplements should be used with caution